Placeholder Banner

BIO Statement on Medicare Part D Changes in Budget Deal

February 8, 2018

Washington, DC (February 8, 2018) – BIO President and CEO Jim Greenwood issued the following statement today regarding proposed changes to the Medicare Part D program in the announced budget deal:

“It is regrettable that such sweeping changes to the successful Medicare Part D program would be considered with so little opportunity for public input or examination of the potential impact on beneficiaries and future biopharmaceutical innovation.

“While we support making out of pocket costs for Part D beneficiaries more affordable, the vast majority of savings from this proposal will accrue to the insurance companies that sponsor Part D plans, rather than patients. America’s biopharmaceutical industry pours far more of its earnings back into R&D than any other sector, approximately 20 percent of all revenue, as companies tirelessly seek to discover new treatments and cures for patients in need. Forcing companies to divert billions of dollars from the research lab to bail out insurance companies will stifle innovation while doing little to save costs for Medicare beneficiaries.

“We stand ready to work with Congress to craft a better solution that encourages reinvestment in the development of innovative new treatments and cures.”

Discover More
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
Washington, D.C. (July 29, 2020) – The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Board leadership. Sylvia Wulf, CEO of AquaBounty Technologies, Inc., and Brian…